Features | Partner Sites | Information | LinkXpress
Sign In
RANDOX LABORATORIES
GLOBETECH PUBLISHING
FOCUS DIAGNOSTICS, INC.

New Capping System Simplifies Storage of Blood and Urine Samples

By Labmedica International staff writers
Posted on 18 Feb 2014
Image: The Novitain Capcluster-50 offers a rapid and economical solution for capping 50 individual sample tubes (Photo courtesy of Micronic Europe BV).
Image: The Novitain Capcluster-50 offers a rapid and economical solution for capping 50 individual sample tubes (Photo courtesy of Micronic Europe BV).
Image: The Novitain Manual Capper CV750 can evenly cap 50 tubes in less than two seconds (Photo courtesy of Micronic Europe BV).
Image: The Novitain Manual Capper CV750 can evenly cap 50 tubes in less than two seconds (Photo courtesy of Micronic Europe BV).
A novel system for re-capping sample tubes permits secure storage of blood and urine specimens for several days in case additional tests need to be performed.

Blood and urine samples are usually collected in vacuum tubes before being sent to a central laboratory for analysis. Following analytical testing, the vacuum tubes require storage for several days in case additional or follow-up tests need to be performed. To simplify the sample retention process Micronic Europe BV (Lelystad, The Netherlands) has introduced a unique postanalytical capping solution for blood or urine sample collection tubes.

The system comprises the Novitain Manual Capper CV750 instrument and Novitain Capcluster-50 multi-caps. The Novitain TPE Push Caps that make up the Capcluster-50 were designed to seal 13-mm diameter sample-collection tubes in a 50-tube format. The caps are manufactured from a chemically resistant medical grade hydrophobic polymer to ensure stored sample integrity.

The Novitain Manual Capper CV750 is an easy-to-use, stand-alone instrument. To seal sample tubes, a Novitain Capcluster-50 sheet is placed on the rack of sample tubes, and the rack is inserted into the Novitain Manual Capper CV750 rack entrance. A simple forward/reverse action of the black handle evenly caps all 50 tubes in less than two seconds. Following the capping step, the Novitain Capcluster-50 retaining foil can be easily removed to leave each individual tube securely capped. The tubes can be opened again using the tab attached to each cap without the need for additional tools.

Related Links:

Micronic Europe BV



PURITAN MEDICAL
Sekisui Diagnostics
EUROIMMUN AG
comments powered by Disqus

Channels

Genetic Tests

view channel
Image: Illumina’s Infinium Human Methylation BeadChip Kits (Photo Courtesy of University of Munster).

Blood Test Developed to Indicate Breast Cancer Risk

A simple blood test to help predict the likelihood of a woman developing breast cancer has been developed, as the idea that genetic mutations are the sole contributors to the development of the disease is changing.... Read more

Immunology

view channel
Image: Histopathology of a kidney showing membranous glomerulonephritis (Photo courtesy of University of Utah).

Noninvasive Test Helps Identify Cause of Specific Kidney Disease

The first test that can help determine a specific type of kidney disease, called membranous glomerulonephritis (MGN) has been authorized for marketing. Membranous glomerulonephritis (MGN) is a chronic... Read more

Pathology

view channel
Image: The heart biopsy procedure is most often done by inserting the biopsy instrument (bioptome) through a small incision in the skin on the right side of the neck. Four or five separate pieces of tissue are needed for adequate sampling (Photo courtesy of Stanford Hospital).

Blood-Based DNA Test May Replace Heart Biopsy for Detecting Transplant Rejection

In a proof-of-principle study, a noninvasive DNA-based blood test was found to be more accurate than the standard heart biopsy procedure for detecting heart transplant rejection. In a search for alternatives... Read more

Industry News

view channel

Fewer Regulatory Barriers in Europe Benefit Companion Diagnostics Sector

The growth in personalized medicine has led to increased interest in companion diagnostics (CDx) tests or tests that match the right therapy to the patient. Over the past few years, market participants have been entering pharmaceutical and diagnostic partnerships in order to develop and commercialize CDx tests for drugs... Read more
 
Copyright © 2000-2014 Globetech Media. All rights reserved.